Intra-Cellular Therapies Reports First Quarter 2022 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. MU
9. HOOD
10. IBM

Go back to Intra-Cellular Therapies Reports First Quarter 2022 Financial Results and Provides Corporate Update

Intra-Cellular Therapies (ITCI) Tops Q1 EPS by 14c

May 10, 2022 7:37 AM EDT

Intra-Cellular Therapies (NASDAQ: ITCI) reported Q1 EPS of ($0.78), $0.14 better than the analyst estimate of ($0.92). Revenue for the quarter came in at $35 million versus the consensus estimate of $33.65 million.

For earnings history and earnings-related data on Intra-Cellular Therapies (ITCI) click here.

... More